Publisher's Synopsis
Live vaccines have long been recognized as being better able to stimulate protective immune responses than inactivated vaccine preparations. There has been renewed interest in their development because of the introduction of recombinant DNA technology and increasing knowledge about bacterial and viral pathogenicity.;This volume deals with the efficacy and safety of both viral and bacterial live vaccines with an emphasis on non-target effects in other individuals or species. The reviews provide detailed information on a range of vaccines for many different diseases and describes strategies for combatting non-target effects. Live vaccines with a history of field use are reviewed, as are newer vaccines undergoing development or trial. Vectored bacterial and viral vaccines for human and animal use are also considered.
